Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease

Abstract Adipocyte hypertrophy and expression of adipokines in subcutaneous adipose tissue (SAT) have been linked to steatosis, nonalcoholic steatohepatitis (NASH) and fibrosis in morbidly obese (BMI ≥ 40 kg/m2) subjects. It is unknown if this is also true for subjects with NAFLD with lesser degrees...

Full description

Bibliographic Details
Main Authors: Magnus Holmer, Hannes Hagström, Ping Chen, Olof Danielsson, Myriam Aouadi, Mikael Rydén, Per Stål
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-24482-1
_version_ 1811315317389918208
author Magnus Holmer
Hannes Hagström
Ping Chen
Olof Danielsson
Myriam Aouadi
Mikael Rydén
Per Stål
author_facet Magnus Holmer
Hannes Hagström
Ping Chen
Olof Danielsson
Myriam Aouadi
Mikael Rydén
Per Stål
author_sort Magnus Holmer
collection DOAJ
description Abstract Adipocyte hypertrophy and expression of adipokines in subcutaneous adipose tissue (SAT) have been linked to steatosis, nonalcoholic steatohepatitis (NASH) and fibrosis in morbidly obese (BMI ≥ 40 kg/m2) subjects. It is unknown if this is also true for subjects with NAFLD with lesser degrees of obesity (BMI < 35 kg/m2). Thirty-two subjects with biopsy-proven NAFLD and 15 non-diabetic controls matched for BMI underwent fine-needle biopsies of SAT. Adipocyte volume was calculated. RNA-sequencing of SAT was performed in a subset of 20 NAFLD patients. Adipocyte volume and gene expression levels were correlated to the presence of NASH or significant fibrosis. Subjects with NAFLD had larger adipocyte volume compared with controls, (1939 pL, 95% CI 1130–1662 vs. 854 pL, 95% CI 781–926, p < 0.001). There was no association between adipocyte volume and the presence of NASH. Gene expression of adipokines previously described to correlate with NASH in morbid obesity, was not associated with NASH or fibrosis. Our results suggest that persons with NAFLD have larger SAT adipocytes compared with controls and that adipocytes are involved in the pathophysiology of hepatic steatosis in NAFLD. However, adipocyte volume was not associated with NASH or fibrosis in NAFLD subjects with varying degrees of obesity.
first_indexed 2024-04-13T11:28:07Z
format Article
id doaj.art-ec6e91cb84394d3cbf060230f277580a
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T11:28:07Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-ec6e91cb84394d3cbf060230f277580a2022-12-22T02:48:38ZengNature PortfolioScientific Reports2045-23222022-11-011211810.1038/s41598-022-24482-1Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver diseaseMagnus Holmer0Hannes Hagström1Ping Chen2Olof Danielsson3Myriam Aouadi4Mikael Rydén5Per Stål6Division of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University HospitalDivision of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University HospitalDepartment of Medicine, Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University HospitalDivision of Pathology, Department of Laboratory Medicine, Huddinge, Karolinska Institutet, Karolinska University HospitalDepartment of Medicine, Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University HospitalEndocrinology Unit, Department of Medicine, Huddinge, Karolinska Institutet, Karolinska University HospitalDivision of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University HospitalAbstract Adipocyte hypertrophy and expression of adipokines in subcutaneous adipose tissue (SAT) have been linked to steatosis, nonalcoholic steatohepatitis (NASH) and fibrosis in morbidly obese (BMI ≥ 40 kg/m2) subjects. It is unknown if this is also true for subjects with NAFLD with lesser degrees of obesity (BMI < 35 kg/m2). Thirty-two subjects with biopsy-proven NAFLD and 15 non-diabetic controls matched for BMI underwent fine-needle biopsies of SAT. Adipocyte volume was calculated. RNA-sequencing of SAT was performed in a subset of 20 NAFLD patients. Adipocyte volume and gene expression levels were correlated to the presence of NASH or significant fibrosis. Subjects with NAFLD had larger adipocyte volume compared with controls, (1939 pL, 95% CI 1130–1662 vs. 854 pL, 95% CI 781–926, p < 0.001). There was no association between adipocyte volume and the presence of NASH. Gene expression of adipokines previously described to correlate with NASH in morbid obesity, was not associated with NASH or fibrosis. Our results suggest that persons with NAFLD have larger SAT adipocytes compared with controls and that adipocytes are involved in the pathophysiology of hepatic steatosis in NAFLD. However, adipocyte volume was not associated with NASH or fibrosis in NAFLD subjects with varying degrees of obesity.https://doi.org/10.1038/s41598-022-24482-1
spellingShingle Magnus Holmer
Hannes Hagström
Ping Chen
Olof Danielsson
Myriam Aouadi
Mikael Rydén
Per Stål
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
Scientific Reports
title Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
title_full Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
title_fullStr Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
title_full_unstemmed Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
title_short Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
title_sort associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
url https://doi.org/10.1038/s41598-022-24482-1
work_keys_str_mv AT magnusholmer associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT hanneshagstrom associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT pingchen associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT olofdanielsson associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT myriamaouadi associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT mikaelryden associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease
AT perstal associationsbetweensubcutaneousadipocytehypertrophyandnonalcoholicfattyliverdisease